ES2139061T3 - Preparado para la piel y las mucosas, con contenido en acido nitrico. - Google Patents

Preparado para la piel y las mucosas, con contenido en acido nitrico.

Info

Publication number
ES2139061T3
ES2139061T3 ES94810364T ES94810364T ES2139061T3 ES 2139061 T3 ES2139061 T3 ES 2139061T3 ES 94810364 T ES94810364 T ES 94810364T ES 94810364 T ES94810364 T ES 94810364T ES 2139061 T3 ES2139061 T3 ES 2139061T3
Authority
ES
Spain
Prior art keywords
skin
mucouses
prepared
content
nitric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94810364T
Other languages
English (en)
Inventor
Michael Grabo
Christian Stahli
Rudolf Meyer
Rene Glauser
Murray Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel AG filed Critical Solco Basel AG
Application granted granted Critical
Publication of ES2139061T3 publication Critical patent/ES2139061T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

MEDIANTE LA TRANSFORMACION DE 1 45 HASTA 170 MMOL PRIMARIAS DE C1 NITRICO SE OBTIENE UN PREPARADO MEJORADO PARA EL TRATAMIENTO LOCAL DE MODIFICACIONES DE LA PIEL Y DE LA MUCOSA Y DE INFECCIONES DE LA PIEL Y DE LA MUCOSA. EL PREPARADO SE COMPONE A PARTIR DE 1 ITRATO EN UNA CONCENTRACION, QUE CORRESPONDE DESDE 0,1 HASTA 6 MG DE NITRITO POR ML DE SOLUCION. SE CARACTERIZA A TRAVES DE UNA BUENA EFECTIVIDAD Y UN RIESGO REDUCIDO DE EFECTO ASOCIADO.
ES94810364T 1993-06-23 1994-06-21 Preparado para la piel y las mucosas, con contenido en acido nitrico. Expired - Lifetime ES2139061T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH188793 1993-06-23

Publications (1)

Publication Number Publication Date
ES2139061T3 true ES2139061T3 (es) 2000-02-01

Family

ID=4220925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94810364T Expired - Lifetime ES2139061T3 (es) 1993-06-23 1994-06-21 Preparado para la piel y las mucosas, con contenido en acido nitrico.

Country Status (11)

Country Link
US (1) US5573786A (es)
EP (1) EP0630650B1 (es)
JP (1) JP3568986B2 (es)
KR (1) KR100297965B1 (es)
CN (1) CN1081919C (es)
AT (1) ATE184796T1 (es)
DE (1) DE59408761D1 (es)
ES (1) ES2139061T3 (es)
MY (1) MY128187A (es)
PL (1) PL174410B1 (es)
RU (1) RU2118160C1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
US6572580B2 (en) 1998-08-06 2003-06-03 Profoot, Inc. Set depth nail notcher with patch system and method for treating nail fungus
US6264628B1 (en) 1998-08-06 2001-07-24 Profoot, Inc. Set depth nail notcher and method for treating nail fungus
US6287276B1 (en) 1998-08-06 2001-09-11 Profoot, Inc. Set depth nail notcher and method for treating nail fungus
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20060057133A1 (en) * 2002-03-22 2006-03-16 Ramon Suarez Mendoza Topical pathogenic-tissue-destroying liquid
EP1746082A1 (en) 2005-07-19 2007-01-24 Anatoly Fyodorovich Tsyb Salts of zinc and aliphatic haloid carboxylic acids for therapy of skin neoplasms and visible mucous coats
RS52576B (en) * 2007-11-07 2013-04-30 Gojko DUNKIĆ CHEMICAL PREPARATION FOR THE SUCCESSFUL REMOVAL OF BENIG LESIONS AND THE PROCEDURE OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY
ATE525077T1 (de) 2008-01-25 2011-10-15 Auriga Internat Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.

Also Published As

Publication number Publication date
CN1103291A (zh) 1995-06-07
ATE184796T1 (de) 1999-10-15
KR100297965B1 (ko) 2001-10-24
EP0630650B1 (de) 1999-09-22
MY128187A (en) 2007-01-31
JP3568986B2 (ja) 2004-09-22
KR950000156A (ko) 1995-01-03
CN1081919C (zh) 2002-04-03
JPH0789861A (ja) 1995-04-04
US5573786A (en) 1996-11-12
EP0630650A1 (de) 1994-12-28
RU2118160C1 (ru) 1998-08-27
DE59408761D1 (de) 1999-10-28
PL174410B1 (pl) 1998-07-31
PL303947A1 (en) 1995-01-09

Similar Documents

Publication Publication Date Title
ES2139061T3 (es) Preparado para la piel y las mucosas, con contenido en acido nitrico.
ES2168334T3 (es) Composicion para el tratamiento de la piel.
ES2155473T3 (es) Composicion veterinaria que contiene un inhibidor de las bombas de protones.
ES2143132T3 (es) Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion.
BR9906287A (pt) Bactéria pertencente ao gênero escherichia e que tem uma capacidade para produzir um l-aminoácido, e, processo para produzir um l-aminoácido
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
ES2038122T3 (es) Un procedimiento para la preparacion de una composicion veterinaria2.
ATE324105T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung von entzündungserkrankungen von kopf und nacken
TR199700855T1 (xx) 1,3-Propandiol-esasl� poliesterlerin haz�rlanmas�nda yan �r�n ak�m�n�n ar�t�lmas�.
HK1037142A1 (en) Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
ES2117349T3 (es) Procedimiento para la purificacion de acido (met)acrilico en bruto.
ES2088877T3 (es) Procedimiento de preparacion del 3-pirrolidinol.
ATE197545T1 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
CO5021217A1 (es) Composiciones estables de mitoxantrona, procedimietno para prepararlas; utilizacion de dichas composiciones y medica- mentos que incluyen dichas soluciones para el tratamiento de enfermedades cancerosas
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
KR950700685A (ko) 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac)
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
Whittle Calcium and the inhibition of histamine release from rat peritoneal mast cells by non-steroid anti-inflammatory agents [proceedings].
RU94045125A (ru) Способ лечения рака матки и яичников
MD1980C2 (ro) Metodă de restabilire a microbiocenozei vaginului la lăuze
ATE454168T1 (de) Calcium-ergänzung zur senkung des risikos für prostatakrebs
SU1824731A1 (ru) Способ лечения гнойно-некротических заболеваний копыт у крупного рогатого скота
ES2189639A1 (es) Composicion acuosa que contiene acido acetilsalicilico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630650

Country of ref document: ES